About Forkhead box protein N3
Forkhead box protein N3 (FOXN3) is a protein
from Homo sapiens identified by UniProt accession
O00409, 490 residues long.
MolForge cross-references it against 0 known binders and
134 disease associations.
Target properties
| Protein name | Forkhead box protein N3 |
| UniProt accession | O00409 |
| Gene | FOXN3 |
| Organism | Homo sapiens |
| Length | 490 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (134)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.47
- glucose measurement · score 0.47
- sex hormone-binding globulin measurement · score 0.47
- high density lipoprotein cholesterol measurement · score 0.45
- electrocardiography · score 0.44
- self reported educational attainment · score 0.42
- testosterone measurement · score 0.42
- heel bone mineral density · score 0.38
- intelligence · score 0.38
- HbA1c measurement · score 0.36
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O00409-F1 | alphafold | PREDICTED | 57.62 | — |
Amino-acid sequence (490 residues)
MGPVMPPSKK PESSGISVSS GLSQCYGGSG FSKALQEDDD LDFSLPDIRL EEGAMEDEEL TNLNWLHESK NLLKSFGESV LRSVSPVQDL DDDTPPSPAH SDMPYDARQN PNCKPPYSFS CLIFMAIEDS PTKRLPVKDI YNWILEHFPY FANAPTGWKN SVRHNLSLNK CFKKVDKERS QSIGKGSLWC IDPEYRQNLI QALKKTPYHP HPHVFNTPPT CPQAYQSTSG PPIWPGSTFF KRNGALLQDP DIDAASAMML LNTPPEIQAG FPPGVIQNGA RVLSRGLFPG VRPLPITPIG VTAAMRNGIT SCRMRTESEP SCGSPVVSGD PKEDHNYSSA KSSNARSTSP TSDSISSSSS SADDHYEFAT KGSQEGSEGS EGSFRSHESP SDTEEDDRKH SQKEPKDSLG DSGYASQHKK RQHFAKARKV PSDTLPLKKR RTEKPPESDD EEMKEAAGSL LHLAGIRSCL NNITNRTAKG QKEQKETTKN
Explore Forkhead box protein N3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets